InsidersTradesSigma
Trillium Therapeutics Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Trillium Therapeutics Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Trillium Therapeutics Inc. has recorded 12 public disclosures. The latest transaction was reported on 19 November 2021 (Disposition). Among the most active insiders: Uger Robert. All data is openly available.
12
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
4 ops.
Sell Volume
27Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 19 November 2021
Declarations12 total
75 sharesCommon SharesSEC:0001104659-21-141749
5,736,363 shares0Common SharesSEC:0001209191-21-065762
75 sharesCommon SharesSEC:0001104659-21-141749:0
5,736,363 shares0Common SharesSEC:0001209191-21-065762:0
3,646 shares@ US$0.303933.2% of flowCommon SharesSEC:0001062993-21-006419
3,646 shares@ US$0.303916.6% of flowCommon SharesSEC:0001062993-21-006419:0
3,646 shares@ US$0.31516.7% of flowCommon SharesSEC:0001062993-21-005487:0
3,646 shares@ US$0.31516.7% of flowCommon SharesSEC:0001062993-21-005487
87,500 shares@ US$0.446250.0% of flowCommon SharesSEC:0001062993-21-004511
87,500 shares@ US$0.446250.0% of flowCommon SharesSEC:0001062993-21-004511:0
3,646 shares@ US$0.31316.7% of flowCommon SharesSEC:0001062993-21-004390:0
3,646 shares@ US$0.31316.7% of flowCommon SharesSEC:0001062993-21-004390
12 of 12 declarations
